Seven established cell lines, including both epithelial cells and fibroblasts (MDCK, Vero, CV-1, NRK, 3T3, F2408, and NIL8) and four early passage cell strains (bovine articular chondrocytes, bovine smooth muscle cells, human foreskin fibroblasts, and rat embryo cells) were cultured in serum-free medium supplemented with milk obtained 1 day after birth (colostrum) or 80 days after birth (older milk). MDCK, Vero, CV-1, NRK, and 3T3 grew readily in colostrum and attained saturation densities ranging from 22% to 63% of that in serum. There was no growth of F2408, NIL8, or the early passage strains in bovine colostrum. None of the 11 cell cultures grew in older milk. The temporal dependence of growth in milk was examined in detail using MDCK cells. Growth equivalent to that in serum occurred in 3% colostrum and in 15% milk obtained 2 days after birth. Milk obtained 3 days and 10 days after birth was not effective as a growth supplement for MDCK cells at any concentration. Those cells, unable to grow in colostrum or in older milk, could be induced to grow if culture dishes were precoated with fibronectin. In addition to fibronectin, it was necessary in some cultures to supplement colostrum or older milk with insulin and/or transferrin in order to achieve growth. In the presence of fibronectin and appropriate factors, the final saturation density attained in colostrum or older milk ranged from 25% to 100% of that in serum. The fibronectin contents of bovine colostrum and milk were determined. The fibronectin level of colostrum was found to be approximately 5% of bovine serum. There was no detectable fibronectin in the 80-day-old milk.

Implantable drug-delivery microdevices are a key diagnostic and therapeutic tool in medicine with increasing applications. Preparation of such combination drug-delivery devices for human studies requires the development of methods to ensure sterility, safety and integrity on both the device and drug side. Despite growing applications for these technologies, there has been a lack of clear methodology regarding sterilization and preparation to meet strict guidelines set forth by the Food and Drug Administration (FDA). Our laboratory developed a set of widely applicable and straightforward procedures to prepare drug-device combination products for clinical use that consistently achieve the high-quality standards provided by the FDA. This includes several newly developed methods for preparation of the implant including endotoxin removal, appropriate sterilization of raw materials, formulation of novel pharmaceutical agents, and loading of agents into drug delivery reservoirs. We also discuss protocols and methods developed with FDA to meet regulatory guidelines to ensure continual sterility and endotoxin testing, as well as longer-term stability testing of drugs and biologic agents. Endotoxin removal and sterilization of raw materials for clinical use. Formulation and device loading of novel pharmaceutical agents. Continued testing of pharmaceutical agents and devices to meet regulatory guidelines.

Prolonged drought due to climate change has negatively impacted amphibians in southern California, U.S.A. Due to the severity and length of the current drought, agencies and researchers had growing concern for the persistence of the arroyo toad (Anaxyrus californicus), an endangered endemic amphibian in this region. Range-wide

No abstract

Climate change and prolonged drought have negatively impacted amphibians in southern California, U.S.A. Due to the severe drought from 2012–2016, agencies and researchers had growing concern for the persistence of the arroyo toad (Anaxyrus californicus), an endangered endemic amphibian in this region. Range-wide surveys for this species had not been conducted for at least 20 years. In 2017–2020 we conducted collaborative surveys for arroyo toads at historical locations. We surveyed 87 of the 115 total sites having historical records and confirmed that the arroyo toad is currently extant in 60 of 87 sites and 19 of 25 historically occupied watersheds. Only detection/non-detection and not population size was recorded, therefore potential declines at the population level could not be assessed. In other amphibian species, body condition has been documented to decrease with a decrease in water availability. To further investigate the drought’s impact on this species, we calculated an average body condition index annually for arroyo toads using allometric measurements recorded from 1996–present. This index was plotted against precipitation records over time. Our data show that body condition did not significantly change during drought years, but hydro-regulation may be masking an effect. Our study suggests that this species shows some resiliency to climate change and drought, and that mitigating invasive species, hydro-modification, and other anthropogenic drivers may currently be the most beneficial strategy for toad conservation. Arroyo toad conservation actions may also provide simultaneous benefits to several other native species that share the same habitat.

No abstract